# Laguna Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/laguna-pharmaceuticals

- Industry: Biotechnology
- Headquarters: US
- Website: www.chanrx.com
- Total disclosed funding: $32M
- Latest round: Series B (Feb 17, 2015)
- Investors on record: 4

## About

Founded in 2006 and based in California, US, Laguna Pharmaceuticals Inc., formerly known as ChanRx Corp., operates as a biopharmaceutical company that develops vanoxerine, a compound used to treat an increasingly common arrhythmia that can cause heart attacks and strokes called atrial fibrillation.

## Funding rounds

- Series B, Feb 17, 2015, $30M — Frazier Healthcare Partners, Versant Ventures, Sante Ventures, BioMed Ventures
- Series A, Nov 21, 2011, $1.9M — Sante Ventures

## Investors

- Sante Ventures (https://capitalatlas.ai/funds/sante-ventures) — Series A, Series B
- Frazier Healthcare Partners (https://capitalatlas.ai/funds/frazier-healthcare-partners) — Series B
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series B
- BioMed Ventures — Series B